HSPBP1
Hsp70-binding protein 1
Also known as: FES1, HPBP1_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9NZL4
- Gene
- HSPBP1
- Ensembl
- ENSG00000133265
- Chromosome
- 19
- Canonical length
- 359 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Vesicles,Centrosome,Cytosol
OverviewNCBI Gene
Enables molecular sequestering activity and ubiquitin protein ligase binding activity. Involved in positive regulation of proteasomal ubiquitin-dependent protein catabolic process and positive regulation of protein ubiquitination. Is active in extracellular space. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
359 residues, UniProt reviewed canonical sequence.
>Q9NZL4|HSPBP1
1 MSDEGSRGSR LPLALPPASQ GCSSGGGGGG SSAGGSGNSR PPRNLQGLLQ MAITAGSEEP
61 DPPPEPMSEE RRQWLQEAMS AAFRGQREEV EQMKSCLRVL SQPMPPTAGE AEQAADQQER
121 EGALELLADL CENMDNAADF CQLSGMHLLV GRYLEAGAAG LRWRAAQLIG TCSQNVAAIQ
181 EQVLGLGALR KLLRLLDRDA CDTVRVKALF AISCLVREQE AGLLQFLRLD GFSVLMRAMQ
241 QQVQKLKVKS AFLLQNLLVG HPEHKGTLCS MGMVQQLVAL VRTEHSPFHE HVLGALCSLV
301 TDFPQGVREC REPELGLEEL LRHRCQLLQQ HEEYQEELEF CEKLLQTCFS SPADDSMDRLocalizationUniProt · AlphaFold · HPA
Whether an antibody against HSPBP1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 118 nTPM
Expression across tissuesHPA
Tissue
- basal ganglia: 118 nTPM
- cerebral cortex: 79 nTPM
- hippocampal formation: 71 nTPM
- amygdala: 65 nTPM
- hypothalamus: 55 nTPM
- heart muscle: 45 nTPM
Single-cell type
- respiratory ciliated cells: 145 nCPM
- epididymal efferent duct ciliated cells: 137 nCPM
- fallopian tube ciliated cells: 110 nCPM
- esophageal basal cells: 91 nCPM
- esophageal suprabasal cells: 84 nCPM
- endometrial ciliated cells: 84 nCPM
Immune cell
- naive B-cell: 65 nTPM
- memory B-cell: 54 nTPM
- myeloid DC: 53 nTPM
- intermediate monocyte: 45 nTPM
- memory CD8 T-cell: 45 nTPM
- NK-cell: 44 nTPM
Brain region
- basal ganglia: 70 nTPM
- cerebral cortex: 61 nTPM
- midbrain: 53 nTPM
- hippocampal formation: 53 nTPM
- amygdala: 52 nTPM
- cerebellum: 52 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.65
- gnomAD pLI
- 0.06
- gnomAD missense Z
- 1.04
- DepMap mean gene effect
- 0.16
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- positive regulation of proteasomal ubiquitin-dependent protein catabolic process
- positive regulation of protein ubiquitination
- protein folding
Molecular functions
- adenyl-nucleotide exchange factor activity
- enzyme inhibitor activity
- molecular sequestering activity
- ubiquitin protein ligase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of HSPBP1 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads HSPBP1 as an antibody target. Whether an autoantibody or antibody against HSPBP1 could matter depends on whether native HSPBP1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
HSPBP1 is annotated as secreted, so native HSPBP1 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label HSPBP1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...